Variables | N | Poor Recovery | ||
---|---|---|---|---|
OR (95% CI) | P value | P for interaction | ||
Age, years | ||||
 < 60 | 261 | 1.33 (1.19–1.49) | < 0.001 | 0.774 |
 ≥60 | 63 | 1.28 (1.10–1.63) | 0.048 | |
Sex | ||||
 Male | 93 | 1.26 (1.09–1.47) | 0.003 | 0.520 |
 Female | 231 | 1.43 (1.23–1.67) | < 0.001 | |
Hypertension | ||||
 No | 279 | 1.33 (1.19–1.49) | < 0.001 | 0.701 |
 Yes | 45 | 1.27 (1.02–1.57) | 0.031 | |
Initial EDSS | ||||
 < 6 | 206 | 1.38 (1.19–1.61) | < 0.001 | 0.188 |
 ≥6 | 118 | 1.21 (1.07–1.37) | < 0.003 | |
Anti-AQP4 antibodies | ||||
 Negative | 91 | 1.34 (1.10–1.63) | 0.004 | 0.819 |
 Positive | 180 | 1.38 (1.19–1.60) | < 0.001 | |
LETM | ||||
 No | 55 | 1.20 (0.96–1.50) | 0.114 | 0.705 |
 Yes | 165 | 1.26 (1.12–1.42) | < 0.001 | |
Immunoglobulins | ||||
 No | 291 | 1.31 (1.18–1.45) | < 0.001 | 0.573 |
 Yes | 33 | 1.46 (0.99–2.15) | 0.057 | |
Immunosuppressants | ||||
 No | 213 | 1.28(1.15–1.43) | < 0.001 | 0.274 |
 Yes | 111 | 1.46 (0.99–2.15) | < 0.001 | |
PLR | ||||
 < 190 | 234 | 1.44 (1.18–1.76) | < 0.001 | 0.090 |
 ≥190 | 90 | 1.18 (1.05–1.33) | < 0.001 | |
LMR | ||||
 < 2.85 | 96 | 1.28 (1.09–1.52) | 0.003 | 0.728 |
 ≥2.85 | 228 | 1.24 (1.09–1.40) | < 0.001 | |
DMT | ||||
 NO | 279 | 1.32 (1.18–1.48) | < 0.001 | 0.312 |
 YES | 45 | 1.18(1.00–1.39) | 0.051 |